Clinical Trial Update: Deucravacitinib Adherence Study [NA]

View source ↗

Summary

Clinical trial update for NCT05570955 evaluating adherence to deucravacitinib in psoriasis. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Psoriasis | NA | Status: ACTIVE_NOT_RECRUITING